EGFR and nasopharyngeal carcinoma: Both the mNSC proliferation assay in the presence/absence of EGF and the inhibition of EGFR suggests that EPIREGULIN mediates NPC proliferation, resulting in altered cell type proportions, via EGFR-mediated signaling.